(PharmaNewsWire.Com, January 07, 2017 ) According to Publisher, the Global Micro-Electro-Mechanical Systems MEMS Medical Devices market is accounted for $3.12 billion in 2015 and is expected to reach $10.41 billion by 2022 growing at a CAGR of 18.7% during the forecast period. Growing occurrence of infectious and chronic diseases, technology advancements and growing aging population are the key factors fueling the market growth. On the other hand, less awareness, rising competition and strict government regulations are hindering the market.
Some of the key players in the market include Honeywell Sensing And Control, MemsTech, CardioMEMS Inc., Agilent Technologies, STMicroelectronics, GE Measurement & Control Solutions, Silicon Microstructures, Inc., Analog Devices, Inc., Omron Corporation, Integrated Sensing Systems, Inc (ISS), Teledyne DALSA, Measurement Specialties, Inc., Caliper Life Sciences, Inc., Knowles Electronics, SVTC Technologies, Micralyne, Inc., Freescale Semiconductor Inc., All Sensors Corporation, Silex Microsystems and Debiotech S.A.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
